Table 4.
Clinical characteristics and demographics of patients underwent post-PTGBD early laparoscopic cholecystectomy (Early group) and post-PTGBD delayed laparoscopic cholecystectomy (Delayed group)
| Early | Delayed | p value | |
|---|---|---|---|
| N = 18 | N = 175 | ||
| Age (years) | |||
| Median (IQR) | 65 (53–78) | 69 (57–77) | 0.493 |
| Mean ± SEM | 63.7 ± 3.49 | 66.3 ± 1.10 | 0.461 |
| > 70 | 7 (38.9%) | 82 (46.9%) | 0.623 |
| Gender | 0.805 | ||
| Male | 9 (50.0%) | 96 (54.9%) | |
| Female | 9 (50.0%) | 79 (45.1%) | |
| Liver cirrhosis | 1 (5.6%) | 3 (1.7%) | 0.326 |
| ≥ 3 Comorbidities | 3 (16.7%) | 24 (13.7%) | 0.722 |
| Abdominal surgical history | 4 (22.2%) | 30 (17.1%) | 0.529 |
| Onset > 72 h | 4 (22.2%) | 41 (23.4%) | 1.000 |
| Fever (BT > 38°) | 10 (55.6%) | 51 (29.1%) | 0.032 |
| SBP on admission | |||
| Median (IQR) | 154 (131–181) | 144 (123–164) | 0.207 |
| Mean ± SEM | 155 ± 7.1 | 145 ± 2.2 | 0.186 |
| Shock (< 90 mmHg) | 0 (0.0%) | 2 (1.1%) | 1.000 |
| Leukocyte (103/µL) | |||
| Median (IQR) | 13.2 (10.5–17.5) | 14.4 (10.4–17.7) | 0.734 |
| Mean ± SEM | 14.1 ± 1.24 | 14.5 ± 0.42 | 0.729 |
| Platelet count (103/µL) | |||
| Median (IQR) | 226.5 (187.0–258.5) | 192.0 (142.0–239.0) | 0.028 |
| Mean ± SEM | 230.5 ± 14.57 | 194.1 ± 4.88 | 0.023 |
| PT-INR | |||
| Median (IQR) | 1.10 (1.10–1.20) | 1.20 (1.10–1.30) | 0.143 |
| Mean ± SEM | 1.14 ± 0.021 | 1.20 ± 0.013 | 0.153 |
| Elevated LFT > 2 times | 2 (12.5%, n = 16) | 26 (15.9%, n = 164) | 1.000 |
| Hyperbilirubinemia | 2 (11.8%, n = 17) | 23 (14.4%, n = 160) | 1.000 |
| Tokyo Guidelines 2018 | 0.464 | ||
| Grade 1 | 7 (38.9%) | 54 (30.8%) | |
| Grade 2 | 10 (55.5%) | 92 (52.6%) | |
| Grade 3 | 1 (5.6%) | 29 (16.6%) | |
| Application of ERCP | 1 (5.6%) | 12 (6.9%) | 1.000 |
| Interval before operation | |||
| Post-PTGBD (day) | |||
| Median (IQR) | 5.8 (4.2–8.1) | 73.0 (56.0–105.0) | < 0.001 |
| Mean ± SEM | 6.5 ± 0.66 | 129.3 ± 18.49 | 0.035 |
*PTGBD, percutaneous transhepatic gallbladder drainage; IQR, interquartile range; SEM, standard error of the mean; SBP, systolic blood pressure; PT-INR, international normalized ratio of prothrombin time; LFT, liver function tests; ERCP, endoscopic retrograde cholangiopancreatography
The results or descriptions highlighted in bold are solely intended to facilitate readers in readily identifying the key points in the tables